• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Organovo

Gerresheimer taps Metzner as CFO | Personnel Moves – December 14, 2018

December 14, 2018 By Fink Densford

Gerresheimer said late last month that it tapped Dr. Bernd Metzner as its new chief financial officer, set to take position at the latest by July 1 next year. Prior to joining the Dusseldorf-based company, Metzner acted as CFO at Ströer, a position he took up in June 2014. He also held positions at Bayer […]

Filed Under: Business/Financial News Tagged With: Aethlon Medical Inc., Amazon, Bayer, Berkshire Hathaway, berkshiresterilemanufacturing, Common Sensing, Frazier Healthcare Ventures, gerresheimer, GI Dynamics, JP Morgan Chase, oculartherapeutix, Organovo, Personnel Moves

Organovo CEO Murphy steps away, Crouch steps up | Personnel Moves | April 14, 2017

April 14, 2017 By MassDevice staff

Organovo (PINK:ONVO) said earlier this week that Taylor Crouch has been appointed as CEO, replacing Keith Murphy who is stepping away from the company. The changes are slated to go into effect on April 21. Prior to being tapped for  the corner office, Crouch operated as CEO of investigative clinical research company eStudySite, the San Diego, […]

Filed Under: Business/Financial News Tagged With: Beaver-Visitec, Bonesupport, Defibtech LLC, GlucoMe, IRRAS, Mizuho OSI, Organovo, precision-image-analysis, Spine Wave, Sunshine Heart Inc.

Organovo unveils bioprinted liver transplant patches

October 5, 2016 By Fink Densford

Organovo (PINK:ONVO) today announced it is developing 3D bioprinted human liver tissue designed for direct transplantation to patients. The move to human development comes based on “strong results” from preclinical animal model studies, the San Diego, Calif.-based company said. The company expects to pursue a formal preclinical development program. “We’re excited to introduce an implantable bioprinted liver […]

Filed Under: Regenerative Medicine Tagged With: Organovo

Organovo launches bio-printed kidney tissue service

September 9, 2016 By Sarah Faulkner

Organovo (PINK:ONVO), the contract research organization known for their 3D bio-printed liver tissue, announced today that it began commercial contracting for its second tissue service, the ExVive Human Kidney. The San Diego, Calif.-based group is widely recognized for their bio-printed liver tissue that pharma giants like Merck and Roche use to assess toxicity for pre-clinical […]

Filed Under: Biotech Tagged With: Organovo

Organovo prices $40m follow-on offering

June 22, 2015 By Fink Densford

Organovo (PINK:ONVO) said last week that it priced a $40 million follow-on offering of 9.4 million shares at $4.25 per share. Proceeds are slated for general corporate purposes, the San Diego, Calif.-based company said, including R&D, commercialization of products and other general expenses. Jefferies LLC and Piper Jaffray & Co. are book-runners for the offering, with […]

Filed Under: Biotech, Business/Financial News Tagged With: 3D printing, Organovo

OvaScience shares up on 1st birth after its fertility treatment

May 7, 2015 By MassDevice Leave a Comment

OvaScience shares up on 1st birth after its fertility treatment

(Reuters) — Shares in OvaScience (NSDQ:OVAS) were up 8% at 1 point today after the company announced the 1st birth of baby resulting from its experimental Augment fertility treatment.

Filed Under: News Well, Stem Cells Tagged With: Obstetrics, Organovo

Organovo inks L’Oreal deal for 3d-printed skin

May 7, 2015 By Mark Hollmer Leave a Comment

Organovo inks L'Oreal deal for 3d-printed skin

Filed Under: Biotech, News Well Tagged With: 3D printing, L'Oreal, Organovo, Tissue Regeneration

Cali biotech promises a 3D-printed organ this year | MassDevice.com On Call

January 7, 2014 By Arezu Sarvestani Leave a Comment

MassDevice.com On Call

MASSDEVICE ON CALL — California biotech startup Organovo has its sights set high, promising to demonstrate the promise of 3D bio-printing technology by unveiling a human organ made of printed living cells by the end the year.

Organovo plans to begin organ-printing with the human liver, constructed by laying down layer after layer of human tissue to form a single organ. To do so, the company needs to develop a sort of vascular system to keep the organ fed with nutrients and oxygen, lest it wither on the printer.

Filed Under: Biotech, News Well Tagged With: On Call, Organ Transplant, Organovo

The 3D medical printing revolution | MassDevice.com On Call

December 17, 2013 By Arezu Sarvestani Leave a Comment

MassDevice.com On Call

MASSDEVICE ON CALL — New 3D printing technology has captured imaginations from NASA labs to art studios, but so-called "bio-printing" may be the revolution with the greatest direct human impact.

Filed Under: News Well Tagged With: Innovation, On Call, Organovo

Boston Scientific hits a new high | Wall Street Beat

April 6, 2013 By Arezu Sarvestani Leave a Comment

MassDevice.com Wall Street Beat

Medtech titan Boston Scientific (NYSE:BSX) started the month strong, hitting a new 52-week Wall Street high of $7.86 on Monday, April 1, and topping that with a new high of $7.95 a day later.

Filed Under: News Well, Wall Street Beat Tagged With: Boston Scientific, ImThera Medical Inc., Organovo, Securities & Exchange Commission (SEC)

Ocular Therapeutix eyes a $24M Series D extension | Wall Street Beat

January 28, 2013 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Ocular Therapeutix said it closed a $23.8 million Series D extension round from existing backers for its sustained drug release technology to treat eye diseases.

The Bedford, Mass.-based medical device company said all of its current institutional investors ponied up for the round, including Polaris Ventures, Versant Ventures, SV Life Sciences, Sparta LLC, and Ascension Health Ventures.

Ocular Therapeutix is developing a punctum plug for the entry of the tear duct to release drug therapy to the surface of the eye over several months.

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic, Wall Street Beat Tagged With: dextera, Given Imaging, InTouch Health, iRobot, oculartherapeutix, Organovo

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS